Among these, miR-26 was found to be related to cancer invasion and metastasis in advanced CTCL through regulation of the IL-22-STAT3-CCL20 pathway. The gene discussed is IL22; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.